Latest Commercialization News

Mineral Resources Limited posted a $896 million statutory loss for FY25, driven by significant impairments, while Onslow Iron achieved commercial production and governance reforms reshape the board.

Trajan Group Holdings Limited reported a 7.4% increase in revenue to $166.5 million for FY25, marking a significant turnaround with a return to profit after tax attributable to owners of $2.2 million. The company also reduced net debt and improved EBITDA by 26.2%, driven by organic growth and strategic acquisitions.

AI-Media Technologies marked FY25 as a pivotal year, transitioning to a technology-led business with 63% of revenue from tech products and launching LEXI Voice. The company expanded its global footprint to 36 countries and set ambitious targets for FY29.

AI-Media Technologies has accelerated its transformation into a technology-led business, reporting a 19% increase in technology revenue and launching its AI-powered LEXI Voice product in FY25.

Ai-Media Technologies reported a 2.1% revenue decline to $64.86 million in FY25, driven by a strategic shift to technology sales and a 25% drop in services revenue. Despite a higher net loss, underlying EBITDA rose 11%, reflecting progress in its SaaS transformation and global expansion.

Everest Metals has received $150,000 from the Minerals Research Institute of Western Australia to advance rubidium extraction at its Mt Edon project, aiming to establish Australia’s first commercial rubidium industry and reduce reliance on Chinese supply chains.

Wesfarmers delivered a solid FY25 with revenue rising 3.4% to $45.7 billion and net profit after tax up 14.4%, driven by strong performances in Bunnings and Kmart. The company announced increased dividends and a proposed capital return, while navigating challenges in its lithium business and ongoing cost pressures.

Wesfarmers Limited reported a 14.4% rise in net profit for FY2025, driven by strong retail performances and strategic portfolio moves. The company also announced a fully-franked final dividend and a significant capital management distribution, signaling confidence amid economic headwinds.

United Overseas Australia Ltd reported a robust half-year profit increase of 31.5%, driven by strong property development and hospitality performance, while declaring a new interim dividend.

Biotron Limited reported a significantly reduced net loss of $318,572 for FY2025, bolstered by a $1.27 million capital raise and a $1.81 million R&D tax rebate, as it advances clinical and preclinical antiviral programs.

Imagion Biosystems reported a $1.66 million loss for the half-year ending June 2025 while progressing its MagSense® HER2 Imaging Agent towards a Phase 2 FDA trial and securing $3.5 million in new funding.

Cyclopharm Limited reported a 26% revenue increase for the half year ended June 2025, driven by rapid US market expansion and strong growth in its Third-Party distribution business. Despite a wider net loss, the company secured a key patent extension and reaffirmed its target to install 250-300 Technegas® systems in the US by late 2026.